MedTrace Logo

Cognitive Behavioral Treatments for Pathological Gambling

NCT00618462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2019-04-09

No results posted yet for this study

Summary

This study will determine the effectiveness of three different treatment strategies in reducing gambling behaviors in pathological gamblers.

Conditions

  • Gambling

Interventions

BEHAVIORAL

Cognitive behavioral therapy (CBT)

CBT will include weekly 50-minute sessions for 8 weeks. The sessions will focus on learning skills to cope with urges to gamble and developing alternatives to gambling.

BEHAVIORAL

Contingency management (CM)

CM will provide incentive, such as a gift certificate to a store or restaurant, for completing activities not related to gambling. Participants and their therapists will decide upon two potential alternative activities to gambling during each therapy session.

BEHAVIORAL

Psychoeducation therapy

Psychoeducation therapy will include weekly 50-minute therapy sessions for 8 weeks. The sessions will focus on education about gambling and related problems.

BEHAVIORAL

Case management

Case management will assist participants in obtaining additional services from the community as needed.

BEHAVIORAL

Gamblers Anonymous (GA)

All participants will be referred to GA, a support group of people who are recovering from gambling addiction, and will be encouraged to attend meetings.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • UConn Health

    lead OTHER

Principal Investigators

  • Nancy M. Petry, PhD · UConn Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00618462 on ClinicalTrials.gov